Galapagos NV(GLPG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLPG Galapagos NV

盘前交易 01-14 04:08:46 EST

33.25

+0.14

+0.42%

最高33.42	最低32.39	成交量15.88万
今开32.82	昨收33.11	日振幅3.11%
总市值21.91亿	流通市值21.63亿	总股本6,590万
成交额526.19万	换手率0.24%	流通股本6,505万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLPG","market":"US","secType":"STK","nameCN":"Galapagos NV","latestPrice":33.25,"timestamp":1768338000000,"preClose":33.11,"halted":0,"volume":158828,"delay":0,"changeRate":0.004228329809725176,"floatShares":65046221,"shares":65897071,"eps":-7.764387,"marketStatus":"盘前交易","change":0.14,"latestTime":"01-14 04:08:46 EST","open":32.82,"high":33.42,"low":32.39,"amount":5261918.43262,"amplitude":0.031108,"askPrice":33.28,"askSize":400,"bidPrice":33.16,"bidSize":1111,"shortable":3,"etf":0,"ttmEps":-7.764387,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768401000000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":1431576000000,"exchange":"NASDAQ","adjPreClose":33.25,"postHourTrading":{"tag":"盘后","latestPrice":33.25,"preClose":33.25,"latestTime":"16:10 EST","volume":1235,"amount":41063.75,"timestamp":1768338603751},"volumeRatio":1.4289004464852733,"impliedVol":0.2112,"impliedVolPercentile":0.368},"requestUrl":"/m/hq/s/GLPG","defaultTab":"news","newsList":[{"id":"1177715479","title":"Galapagos NV：Leerink Partners将评级从“市场表现”上调至“跑赢大盘”；目标价从29美元上调至40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177715479","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177715479?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:12","pubTimestamp":1761131566,"startTime":"0","endTime":"0","summary":"Galapagos NV：Leerink Partners将评级从“市场表现”上调至“跑赢大盘”；目标价从29美元上调至40美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2577881317","title":"未找到“可行”买家，Galapagos 细胞治疗业务关闭","url":"https://stock-news.laohu8.com/highlight/detail?id=2577881317","media":"Minhua笔记","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577881317?lang=zh_cn&edition=full","pubTime":"2025-10-22 16:54","pubTimestamp":1761123284,"startTime":"0","endTime":"0","summary":"10月21日，比利时生物技术公司Galapagos宣布关闭细胞治疗业务，波及欧洲、美国和中国四个国家共计365个岗位。Galapagos，这家以炎症和纤维化药物闻名的比利时生物科技先锋，正以“壮士断腕”姿态告别细胞治疗。10月21日公告显示，Galapagos将逐步关闭细胞疗法业务，涉及荷兰莱顿研发中心、瑞士巴塞尔行政办公室、美国马萨诸塞州波士顿设施和中国上海的设施——这些曾是其CAR-T和干细胞平台的核心。Galapagos的退出并非孤例，而是细胞治疗行业周期低谷的缩影。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022170700a6c7a563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022170700a6c7a563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2577317898","title":"寻买家失败，biotech放弃细胞治疗业务断臂求生","url":"https://stock-news.laohu8.com/highlight/detail?id=2577317898","media":"细胞基因治疗前沿","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577317898?lang=zh_cn&edition=full","pubTime":"2025-10-22 11:08","pubTimestamp":1761102492,"startTime":"0","endTime":"0","summary":"继武田制药和诺和诺德先后宣布退出细胞治疗领域后，又一家biotech宣布关闭细胞业务，细胞治疗赛道正经历新一轮残酷洗牌，行业进入理性收缩与调整阶段。10月21日，Galapgos宣布在对战略替代方案进行全面审查，包括潜在的资产剥离后，最终决定逐步关闭其细胞治疗业务，并利用现有现金资源寻求新的转型业务发展交易。除吉利德任命的两名董事外，Galapagos董事会一致批准了逐步关闭细胞治疗业务的意向，这两名董事均回避了投票。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022114843a46d923b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022114843a46d923b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4546","BK4161","GLPG","DM","CR","SLE","BK4139","BK4077"],"gpt_icon":0},{"id":"1151593914","title":"异动解读 | Galapagos NV股价盘前大跌13.49%，季度业绩远低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1151593914","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151593914?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:07","pubTimestamp":1753344427,"startTime":"0","endTime":"0","summary":"生物制药公司Galapagos NV在周四盘前交易中股价大幅下跌13.49%，主要原因是该公司公布的季度业绩远低于市场预期，引发投资者对公司未来发展的担忧。根据公司最新发布的财报，截至6月30日的季度，Galapagos NV调整后每股亏损1.60欧元，远低于分析师平均预期的每股亏损0.20欧元。值得注意的是，过去三个月中，分析师已经大幅下调了对Galapagos NV的盈利预测，平均预期下降了约1516%。这些因素共同导致了Galapagos NV股价的大幅下跌，抹去了该股今年以来19.2%的涨幅。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GLPG"],"gpt_icon":0},{"id":"1178852422","title":"异动解读 | Galapagos NV股价夜盘暴跌8.02%，季度业绩远低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1178852422","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178852422?lang=zh_cn&edition=full","pubTime":"2025-07-24 15:02","pubTimestamp":1753340578,"startTime":"0","endTime":"0","summary":"生物制药公司Galapagos NV在周四夜盘交易中股价大幅下跌8.02%，主要原因是该公司公布的季度业绩远低于市场预期。根据公司最新发布的财报，截至6月30日的季度，Galapagos NV调整后每股亏损1.60欧元，远低于分析师平均预期的每股亏损0.20欧元。这一糟糕的业绩表现引发了投资者的担忧。值得注意的是，过去三个月中，分析师已经大幅下调了对Galapagos NV的盈利预测，平均预期下降了约1516%。这些因素共同导致了Galapagos NV股价的大幅下跌，抹去了该股今年以来19.2%的涨幅。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GLPG"],"gpt_icon":0},{"id":"1108651982","title":"异动解读 | Galapagos盘中股价大涨5.9%,业务前景获市场看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1108651982","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108651982?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:46","pubTimestamp":1739889980,"startTime":"0","endTime":"0","summary":"生物技术公司Galapagos(GLPG)今天盘中股价大涨5.9%,引发了市场的广泛关注。\n\n从新闻报道来看,该公司近期没有重大利好消息出炉。但公司作为一家生物技术公司,专注于药物发现、开发和商业化,在免疫学、肿瘤学等领域都有丰富的产品线。其首款治疗类风湿关节炎和溃疡性结肠炎的药物已在欧洲和日本上市。\n\n据分析,投资者对Galapagos的业务前景抱有乐观态度,认为公司在多个治疗领域的创新药物将为其带来长期增长空间。这可能是推动该股盘中大涨的主要原因。不过,投资者仍需密切关注公司的研发进展和产品销售情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Galapagos盘中股价大涨5.9%,业务前景获市场看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GLPG"],"gpt_icon":0},{"id":"2512165693","title":"Galapagos Nv盘中异动 股价大涨5.09%报26.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165693?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:36","pubTimestamp":1739889361,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时36分，Galapagos Nv股票出现波动，股价急速拉升5.09%。截至发稿，该股报26.74美元/股，成交量1.921万股，换手率0.03%，振幅0.73%。Galapagos Nv股票所在的生物技术行业中，整体涨幅为0.02%。Galapagos Nv公司简介：Galapagos NV是一家完全一体化的生物技术公司，专注于药物的发掘、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223601a24aadd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223601a24aadd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2511615363","title":"大摩：下调Galapagos(GLPG.US)评级，由持股观望调整至减持评级, 目标价由31.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511615363","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511615363?lang=zh_cn&edition=full","pubTime":"2025-02-15 02:12","pubTimestamp":1739556758,"startTime":"0","endTime":"0","summary":"大摩：下调Galapagos(GLPG.US)评级，由持股观望调整至减持评级, 目标价由31.00美元调整至22.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15021248179487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GLPG"],"gpt_icon":0},{"id":"1121557971","title":"异动解读 | Galapagos股价连续两年业绩下滑 盘前大跌7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121557971","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121557971?lang=zh_cn&edition=full","pubTime":"2025-02-13 17:14","pubTimestamp":1739438056,"startTime":"0","endTime":"0","summary":"据报道,生物制药公司Galapagos(GLPG)盘前股价暴跌7.09%,引起了市场的广泛关注。公司最新公布的财报显示,其2024财年每股收益较上一年大幅下滑近三分之二,仅为1.12欧元。此前2023财年的第四季度营收和每股收益也较去年同期出现较大幅度回落。\n\n分析人士指出,Galapagos连续两年的业绩下滑可能令投资者对公司未来的增长前景缺乏信心,从而引发抛售股票的行为。公司能否扭转收入和盈利的颓势将是重中之重。\n\n不过,公司最新季报显示营收和每股收益仍超出分析师预期,部分分析师认为这一因素或将对股价构成一定支撑。投资者需要密切关注Galapagos的后续发展,并做好应对风险的准备。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GLPG"],"gpt_icon":0},{"id":"1130457097","title":"异动解读 | 盈利超预期 GLPG(Galapagos NV)盘中大涨7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130457097","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130457097?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:26","pubTimestamp":1739395593,"startTime":"0","endTime":"0","summary":"GLPG(Galapagos NV)今日股价盘中大涨7.34%,引发市场关注。公司公布的第四季度财报优于预期,是股价大涨的主要原因。\n\n数据显示,GLPG第四季度每股收益为0.30美元,高于分析师预期的-0.35美元,同比去年同期的2.64美元下降88.64%。营收为8058万美元,超过分析师预期的6930万美元16.27%,但同比去年同期的10215万美元下降了21.12%。\n\n总体来看,尽管GLPG营收同比有所下滑,但公司依然实现了盈利,且每股收益远超预期,反映出公司业绩向好,从而支撑了今日股价表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GLPG"],"gpt_icon":0},{"id":"1122761261","title":"Galapagos第四季度每股收益$0.30, 销售额$80.58百万（已转换为美元）","url":"https://stock-news.laohu8.com/highlight/detail?id=1122761261","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122761261?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:24","pubTimestamp":1739395469,"startTime":"0","endTime":"0","summary":"Galapagos  报告季度每股收益$0.30，超出分析师共识预期的 $，高出了185.71%。与去年同期的$102.15百万销售额相比，下降了21.12%。以上内容来自Benzinga Earnings专栏，原文如下：Galapagos  reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $ by 185.71 percent. This is a 88.64 percent decrease over earnings of $2.64 per share from the same period last year.  The company reported quarterly sales of $80.58 million which beat the analyst consensus estimate of $69.30 million by 16.27 percent.  This is a 21.12 percent decrease","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USD","GLPG"],"gpt_icon":0},{"id":"1150145030","title":"Galapagos FY24每股收益从去年同期的€3.21下降至€1.12；收入从去年同期的€239.7百万上升至€275.6百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1150145030","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150145030?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:17","pubTimestamp":1739395034,"startTime":"0","endTime":"0","summary":"Galapagos FY24每股收益从去年同期的€3.21下降至€1.12；收入从去年同期的€239.7百万上升至€275.6百万以上内容来自Benzinga Earnings专栏，原文如下：Galapagos FY24 EPS €1.12 Down From €3.21 YoY; Revenue €275.6M Up From €239.7M YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Galapagos FY24每股收益从去年同期的€3.21下降至€1.12；收入从去年同期的€239.7百万上升至€275.6百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG"],"gpt_icon":0},{"id":"2503904589","title":"Galapagos Nv盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503904589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503904589?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:04","pubTimestamp":1736780662,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时04分，Galapagos Nv股票出现异动，股价大幅跳水5.13%。截至发稿，该股报24.34美元/股，成交量8.4611万股，换手率0.13%，振幅2.22%。Galapagos Nv股票所在的生物技术行业中，整体跌幅为1.33%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为6123.73%、3571.42%、408.41%，振幅较大的相关个股有Kairos Pharma, Ltd.、Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.，振幅分别为124.54%、121.30%、104.79%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323042296025991&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323042296025991&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2502864715","title":"Galapagos Nv盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502864715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502864715?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519524,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Galapagos Nv股票出现异动，股价急速跳水5.01%。截至发稿，该股报26.76美元/股，成交量2.6716万股，换手率0.04%，振幅0.50%。Galapagos Nv股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为900.31%、130.96%、103.86%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Engene Holdings Inc.，振幅分别为15.25%、10.00%、7.90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223204a21d0dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223204a21d0dc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2502836493","title":"一拆二，直接裁员40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502836493","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502836493?lang=zh_cn&edition=full","pubTime":"2025-01-10 16:01","pubTimestamp":1736496064,"startTime":"0","endTime":"0","summary":"公司停止小分子药物研发，约300名员工被裁。近期，Galapagos公司发布消息，计划将自身拆分为两个独立的上市公司，并且会削减40%的员工队伍。此次Galapagos公司决定拆分，主要是因为其在业务拓展方面遭遇了难题。此次拆分引发了约300名员工的岗位被裁撤，包括公司位于比利时总部以及法国办公室的部分员工。2024年2月，Galapagos实施了一次裁员及业务重组，终止了针对难治性系统性红斑狼疮的CD19 CAR-T管线的开发工作，并且裁减了100名员工。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110161621a21ca305&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110161621a21ca305&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4022","GLPG","BK4094","BK4230","BK4588","FL","BK4139","BK4585","CAR"],"gpt_icon":0},{"id":"2486480303","title":"Galapagos Nv盘中异动 快速上涨5.17%报28.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486480303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486480303?lang=zh_cn&edition=full","pubTime":"2024-11-28 01:47","pubTimestamp":1732729632,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日01时47分，Galapagos Nv股票出现波动，股价大幅上涨5.17%。截至发稿，该股报28.29美元/股，成交量30.27万股，换手率0.46%，振幅3.72%。Galapagos Nv股票所在的生物技术行业中，整体涨幅为0.78%。Galapagos Nv公司简介：Galapagos NV是一家完全一体化的生物技术公司，专注于药物的发掘、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112801471298e44fd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112801471298e44fd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2485295791","title":"Galapagos Nv盘中异动 大幅拉升5.10%报26.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485295791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485295791?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:36","pubTimestamp":1732293398,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时36分，Galapagos Nv股票出现波动，股价急速上涨5.10%。截至发稿，该股报26.51美元/股，成交量10.2795万股，换手率0.16%，振幅1.82%。Galapagos Nv股票所在的生物技术行业中，整体涨幅为0.73%。Galapagos Nv公司简介：Galapagos NV是一家完全一体化的生物技术公司，专注于药物的发掘、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123003638abd7c5f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123003638abd7c5f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"1139853534","title":"异动解读 | Galapagos NV第三季度业绩低于预期 盘前股价重挫8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139853534","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139853534?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:32","pubTimestamp":1730395975,"startTime":"0","endTime":"0","summary":"比利时生物科技公司Galapagos NV今日盘前大跌8.04%,报收36.4欧元,引发市场关注。从财报数据来看,这种股价重挫或受到公司最新季度业绩大幅低于市场预期的影响。在最新公布的2024年第三季度财报中,Galapagos公司调整后每股亏损77美分,远高于分析师此前平均预期的49美分亏损。显然,本季度业绩疲弱和利润前景堪忧令该公司在投资者心中形象大打折扣,加上资金外流,导致其股价在盘前遭遇重挫。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GLPG"],"gpt_icon":0},{"id":"2479080227","title":"Galapagos Nv盘中异动 股价大跌6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080227?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:32","pubTimestamp":1730381561,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时32分，Galapagos Nv股票出现异动，股价大幅下跌6.40%。截至发稿，该股报26.76美元/股，成交量8.6721万股，换手率0.13%，振幅0.91%。Galapagos Nv股票所在的生物技术行业中，整体跌幅为1.85%。Galapagos Nv公司简介：Galapagos NV是一家完全一体化的生物技术公司，专注于药物的发掘、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121324195bd9c2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121324195bd9c2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"1156858224","title":"异动解读 | Galapagos公司财报业绩低于预期 股价盘前大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156858224","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156858224?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:12","pubTimestamp":1730362342,"startTime":"0","endTime":"0","summary":"比利时生物科技公司Galapagos NV今日盘前大跌5.04%,报收36.4欧元。此前,Galapagos公司公布了截至9月30日的最新季度财报,业绩数据低于市场预期,这被视为导致公司股价下跌的主要原因。财报显示,Galapagos本季度调整后每股亏损77美分,而分析师此前平均预期为亏损49美分。同时,过去三个月来,分析师对Galapagos未来盈利的平均预测下降了约155.7%,显示外界对公司前景信心不足。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GLPG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glpg.com","stockEarnings":[{"period":"1week","weight":0.0224},{"period":"1month","weight":0.0492},{"period":"3month","weight":-0.0232},{"period":"6month","weight":0.0845},{"period":"1year","weight":0.3717},{"period":"ytd","weight":0.0168}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Galapagos Nv于1999年6月30日在比利时注册成立。该公司是一家全球性生物技术公司，在欧洲和美国开展业务，致力于为更多年的生命和生活质量开发转化药物。该公司专注于高度未满足的医疗需求，协同引人注目的科学、技术和协作方法，以创建潜在的同类最佳小分子、CAR-T疗法以及肿瘤学和免疫学中的生物制剂的深度管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.027297},{"month":2,"riseRate":0.2,"avgChangeRate":-0.060645},{"month":3,"riseRate":0.4,"avgChangeRate":0.011255},{"month":4,"riseRate":0.6,"avgChangeRate":-0.000231},{"month":5,"riseRate":0.4,"avgChangeRate":0.031125},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.039259},{"month":7,"riseRate":0.636364,"avgChangeRate":0.068834},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.030314},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.018717},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.009712},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.004236},{"month":12,"riseRate":0.727273,"avgChangeRate":0.051262}],"exchange":"NASDAQ","name":"Galapagos NV","nameEN":"Galapagos NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galapagos NV(GLPG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Galapagos NV(GLPG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Galapagos NV,GLPG,Galapagos NV股票,Galapagos NV股票老虎,Galapagos NV股票老虎国际,Galapagos NV行情,Galapagos NV股票行情,Galapagos NV股价,Galapagos NV股市,Galapagos NV股票价格,Galapagos NV股票交易,Galapagos NV股票购买,Galapagos NV股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galapagos NV(GLPG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Galapagos NV(GLPG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}